KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Molina Healthcare (MOH) Other Non-Current Liabilities (2016 - 2025)

Molina Healthcare's Other Non-Current Liabilities history spans 16 years, with the latest figure at $174.0 million for Q3 2025.

  • For Q3 2025, Other Non-Current Liabilities rose 42.62% year-over-year to $174.0 million; the TTM value through Sep 2025 reached $174.0 million, up 42.62%, while the annual FY2024 figure was $120.0 million, 3.23% down from the prior year.
  • Other Non-Current Liabilities for Q3 2025 was $174.0 million at Molina Healthcare, up from $167.0 million in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $174.0 million in Q3 2025 and bottomed at $88.0 million in Q1 2023.
  • The 5-year median for Other Non-Current Liabilities is $122.0 million (2023), against an average of $124.7 million.
  • The largest annual shift saw Other Non-Current Liabilities plummeted 34.33% in 2023 before it soared 42.62% in 2025.
  • A 5-year view of Other Non-Current Liabilities shows it stood at $140.0 million in 2021, then fell by 25.71% to $104.0 million in 2022, then rose by 19.23% to $124.0 million in 2023, then fell by 3.23% to $120.0 million in 2024, then soared by 45.0% to $174.0 million in 2025.
  • Per Business Quant, the three most recent readings for MOH's Other Non-Current Liabilities are $174.0 million (Q3 2025), $167.0 million (Q2 2025), and $155.0 million (Q1 2025).